Security key
501147102
Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (KRYS)
CUSIP: 501147102
Q4 2024 13F Holders as of 31 Dec 2024
- Security type / class
- Equity / Common Stock, $0.00001 par value ("Common Stock")
- Total 13F shares
- 27,774,030
- Total 13F value
- $4,351,782,009
- Share change
- -537,627
- Put/Call ratio
- 60%
- SEC-reported price per share
- $156.66
- Number of holders
- 264
- Value change
- -$92,533,890
- Number of buys
- 123
- Number of sells
- 146
- Shares outstanding
- 29,463,330
Holder snapshot
7 signals
Open additional details 1 more signal available
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2024
Institutions
264
Top holders
10
KRYS full security history
Ownership snapshot
Full 13F holder table
Krystal Biotech, Inc. SEC filings
Krystal Biotech, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of KRYS - Krystal Biotech, Inc. - Common Stock, $0.00001 par value ("Common Stock") (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
STATE STREET CORP
Disclosed value leader
FMR LLC
Comparable rows
15/15
Latest evidence
30 Sep 2024
13F
13D/G
Lead comparable stake: 4.4%
13D/G row: STATE STREET CORP
Showing 1-6 of 15 holder rows.
Quick read
STATE STREET CORP leads the comparable SEC ownership view at 4.4%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens STATE STREET CORP's linked filing trail.
Comparable ownership
Top 5
STATE STREET CORP
4.4%
FMR LLC
15%
BlackRock, Inc.
14%
VANGUARD GROUP INC
9.7%
Avoro Capital Advisors LLC
8.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| STATE STREET CORP |
13F
13D/G
Company · STATE STREET CORPORATION
|
4.4%
from 13D/G
|
$264,455,186
1,452,811 shares
|
— | 30 Sep 2024 |
| FMR LLC |
13F
Company
|
15%
|
$781,433,128
4,292,881 shares
|
— | 30 Sep 2024 |
| BlackRock, Inc. |
13F
Company
|
14%
|
$726,868,180
3,993,123 shares
|
— | 30 Sep 2024 |
| VANGUARD GROUP INC |
13F
Company
|
9.7%
|
$518,738,900
2,849,744 shares
|
— | 30 Sep 2024 |
| Avoro Capital Advisors LLC |
13F
Company
|
8.9%
|
$477,323,071
2,622,222 shares
|
— | 30 Sep 2024 |
| Frazier Life Sciences Management, L.P. |
13F
Company
|
3.4%
|
$179,929,374
988,460 shares
|
— | 30 Sep 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2024
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
264
Shares
27,774,030
Rows available
264
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2024 vs Q3 2024 Across Filers
Q3 2024 holders
281
Q4 2024 holders
264
Holder diff
-17
| Investor | Q3 2024 Shares | Q4 2024 Shares | Share Diff | Share Chg % | Q3 2024 value | Q4 2024 value | Value change | Value Chg % |
|---|